Status:
COMPLETED
Blood Biomarkers in Major Depression
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Depression is a leading cause of disability worldwide, affecting nearly 16% of the general population. Its physiopathology remains unclear. Based on gene-environment studies and epigenetic studies, a ...
Eligibility Criteria
Inclusion
- Major depressive disorder at inclusion according to the DSM IV at the time of the inclusion,
- Having a score on the scale of depression of Hamilton ( HDRS-17) \> 19 at the time of the inclusion,
- Taken care by a grown-up psychiatric department, that the coverage(care) is realized in ambulatory or during a hospitalization
Exclusion
- Schizophrenia
Key Trial Info
Start Date :
February 22 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2022
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT02209142
Start Date
February 22 2012
End Date
November 10 2022
Last Update
April 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, France, 13009